Order Article Reprints

Alzahrani NM, Booq RY, Aldossary AM, Bakr AA, Almughem FA, Alfahad AJ, Alsharif WK, Jarallah SJ, Alharbi WS, Alsudir SA, et al. Liposome-Encapsulated Tobramycin and IDR-1018 Peptide Mediated Biofilm Disruption and Enhanced Antimicrobial Activity against Pseudomonas aeruginosa. Pharmaceutics. 2022; 14(5):960. https://doi.org/10.3390/pharmaceutics14050960

Alzahrani, Nouf M., Rayan Y. Booq, Ahmad M. Aldossary, Abrar A. Bakr, Fahad A. Almughem, Ahmed J. Alfahad, Wijdan K. Alsharif, Somayah J. Jarallah, Waleed S. Alharbi, Samar A. Alsudir, and et al. 2022. "Liposome-Encapsulated Tobramycin and IDR-1018 Peptide Mediated Biofilm Disruption and Enhanced Antimicrobial Activity against Pseudomonas aeruginosa" Pharmaceutics 14, no. 5: 960. https://doi.org/10.3390/pharmaceutics14050960

Alzahrani, N. M., Booq, R. Y., Aldossary, A. M., Bakr, A. A., Almughem, F. A., Alfahad, A. J., Alsharif, W. K., Jarallah, S. J., Alharbi, W. S., Alsudir, S. A., Alyamani, E. J., Tawfik, E. A., & Alshehri, A. A. (2022). Liposome-Encapsulated Tobramycin and IDR-1018 Peptide Mediated Biofilm Disruption and Enhanced Antimicrobial Activity against Pseudomonas aeruginosa. Pharmaceutics, 14(5), 960. https://doi.org/10.3390/pharmaceutics14050960